Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can artificial intelligence stop bedsores before they start?

NCT ID NCT07779395

Disease control Sponsor: Ankara Yildirim Beyazıt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether an artificial intelligence app called PRESS AI can help nurses prevent pressure injuries (bedsores) in adult intensive care patients. The app supports nurses in assessing risk, staging wounds, and planning care. Researchers will compare the rate of new pressure injuries before and after nurses start using the app, to see if it improves prevention and care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PRESS AI, an artificial intelligence-supported mobile clinical decision support application for pressure injury prevention and care
What this could lead to
If effective, PRESS AI could become a standard tool to help nurses prevent painful pressure injuries in hospital intensive care units, improving patient outcomes and reducing healthcare costs.
What could go wrong
This is a single-center study with a moderate number of participants, and the AI is a decision-support tool, not a replacement for clinical judgment. Results may not generalize to other hospitals, and the AI's recommendations could occasionally be inaccurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 174 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older. * Hospitalized in the Anesthesiology and Reanimation Intensive Care Unit of Ankara University Ibni Sina Research and Application Hospital during the pre-intervention or intervention period. * Written informed consent provided by the patient or, when the patient lacks decision-making capacity, by the patient's legally authorized representative. Exclusion Criteria: * Refusal to participate by the patient or legally authorized representative, or withdrawal of previously provided consent. * Missing essential follow-up data required to assess the development of pressure injuries.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pressure injury are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

decubitus ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pressure injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara University Ibni Sina Research and Application Hospital

    RECRUITING

    Ankara, Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.